Stay updated with breaking news from Randomised Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immune Evasion and Receptor Engagement - read this article along with other careers information, tips and advice on BioSpace
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.1 This ...
EMA's CHMP recommended the approval yesterdayApproval based on results from four phase III studies in over 5,500 patientsActemra/RoActemra has also been provisionally approved in Australia for the treatment
Investegate announcements from F. Hoffmann-La Roche Ltd, Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19
The CHMP recommends EU approval for Roche's (RHHBY) Actemra to treat patients with severe COVID-19.